Compare SHIP & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SHIP | CLPT |
|---|---|---|
| Founded | 2008 | 1998 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 335.2M | 353.5M |
| IPO Year | 2008 | 2009 |
| Metric | SHIP | CLPT |
|---|---|---|
| Price | $15.80 | $11.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $17.00 | ★ $20.00 |
| AVG Volume (30 Days) | 216.7K | ★ 476.8K |
| Earning Date | 05-26-2026 | 05-13-2026 |
| Dividend Yield | ★ 2.93% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,971,000.00 |
| Revenue This Year | $20.07 | $45.67 |
| Revenue Next Year | N/A | $19.51 |
| P/E Ratio | $13.34 | ★ N/A |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $5.83 | $8.27 |
| 52 Week High | $16.81 | $30.10 |
| Indicator | SHIP | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 58.12 | 52.99 |
| Support Level | $7.85 | $10.09 |
| Resistance Level | $16.81 | $15.09 |
| Average True Range (ATR) | 0.73 | 0.97 |
| MACD | -0.01 | 0.09 |
| Stochastic Oscillator | 63.19 | 47.74 |
Seanergy Maritime Holdings Corp is an international shipping company that provides marine dry bulk transportation services through a modern fleet of Capesize vessels. It generates a majority of its revenue from the vessels. The company's fleet of vessels includes Blueship, Meiship, Kaizenship, Iconship, Titanship, Flagship, Paroship, Worldship, Hellasship, Partnership, Championship, Patriotship, Dukeship, Honorship, Fellowship, Knightship, Lordship, Premiership, Squireship, and Friendship.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.